The Athens Stock Exchange is looking for the necessary "fuel" in order to climb to 1,500 points, with buyers looking for their feet and sellers securing a part of recent gains.
Since the beginning of the year, after all, the Greek market has offered an impressive return of more than 15.5%, which has brought the main stock index to the edge of 1,500 points - for the first time since April 2011.
Therefore, it is not surprising that some investors are choosing this period of time to increase their liquidity, reaping the benefits of the large ongoing upward movement.
Meanwhile, Q1 corporate results are again in the spotlight, with Alpha Bank, Eurobank, and Helleniq Energy standing out from the list and attracting the most interest.
In more detail, during today's session, the General Index recorded a subtle increase of 0.02% to 1,493.73 points, remaining almost unchanged compared to Wednesday's close (1,493.65 points).
The arc of daily fluctuations extends over five points (from 1,492.73 to 1,497.35 points), with the turnover of transactions ranging at 6 million euros.
On the board, now, the 211 million euro profit in the first quarter is giving a boost to Alpha Bank, which is up around 2%. On the other hand, Ethniki is correcting from yesterday's multi-year highs. Jumbo - Helleniq Energy also show small losses.
The banking index, after 8-year highs, stabilizes at 1,306 points, recording marginal losses of 0.15%.
The share of National Bank retreats -1.41% and 8.38 euros, Eurobank's share declines -0.39% and 2,049 points, Piraeus' share trades +0.41% and 3.90 euros, while Alpha Bank's share dynamically strengthens +1.95% and 1.6725 euros.
In the large-cap index (-0.11% and 3,613 points), Helleniq Energy shares are down 1% and correcting from 4.5-year highs, pending quarterly figures. Jumbo, Lamda, EYDAP, Motor Oil and Mytilineos also show losses of up to 1%. On the other hand, Quest shares gain 0.7%, struggling to return to the 6 euro milestone.
As for the mid-cap index (+0.21% and 2,391 points), Kri-Kri's share stands out positively at +2.8% and 11.1 euros, recovering from the recent correction. Profile and Laipharm shares are also up close to +2%, while Alumyl and ADMIE shares expand by 1%. On the contrary, EXAE and Intrakat lose 1% each.
